Search research articles
Contact Us
Filters
Showing results (791-800 of 853) with videos related to
Page
of 86
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2020
Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial
David A Reardon, Annick Desjardins, James J Vredenburgh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2022
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
Andrew B Lassman, Khê Hoang-Xuan, Mei-Yin C Polley, et al.
The Journal of Clinical Investigation
|
December 15, 2020
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates
Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, et al.
Critical Care (London, England)
|
April 20, 2021
Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study
Pavan K Bhatraju, Eric D Morrell, Leila Zelnick, et al.
Neuro-Oncology Advances
|
April 24, 2026
Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial
Byram H Ozer, Adam L Cohen, Howard Colman, et al.
Blood
|
November 17, 2020
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
M K Gandhi, T Hoang, S C Law, et al.
Annals of Family Medicine
|
March 24, 2026
Effect of an Advanced Community Paramedic Program to Shorten or Prevent Hospitalizations: A Pragmatic, Point-of-Care, Randomized Clinical Trial
Rozalina G McCoy, Michael B Juntunen, Jennifer L Ridgeway, et al.
The Journal of Allergy and Clinical Immunology
|
May 22, 2017
X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability
Beatriz E Marciano, Christa S Zerbe, E Liana Falcone, et al.
Frontiers in Pediatrics
|
February 14, 2022
Global PARITY: Study Design for a Multi-Centered, International Point Prevalence Study to Estimate the Burden of Pediatric Acute Critical Illness in Resource-Limited Settings
Qalab Abbas, Adrian Holloway, Paula Caporal, et al.
Cell Reports. Medicine
|
July 9, 2024
Longitudinal analysis of the lung proteome reveals persistent repair months after mild to moderate COVID-19
Shreya M Kanth, Julio A Huapaya, Salina Gairhe, et al.
Page
of 86
Search research articles
Search
Showing results (791-800 of 853) with videos related to
Sort By:
Page
of 86
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2020
Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial
David A Reardon, Annick Desjardins, James J Vredenburgh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2022
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
Andrew B Lassman, Khê Hoang-Xuan, Mei-Yin C Polley, et al.
The Journal of Clinical Investigation
|
December 15, 2020
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates
Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, et al.
Critical Care (London, England)
|
April 20, 2021
Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study
Pavan K Bhatraju, Eric D Morrell, Leila Zelnick, et al.
Neuro-Oncology Advances
|
April 24, 2026
Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial
Byram H Ozer, Adam L Cohen, Howard Colman, et al.
Blood
|
November 17, 2020
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
M K Gandhi, T Hoang, S C Law, et al.
Annals of Family Medicine
|
March 24, 2026
Effect of an Advanced Community Paramedic Program to Shorten or Prevent Hospitalizations: A Pragmatic, Point-of-Care, Randomized Clinical Trial
Rozalina G McCoy, Michael B Juntunen, Jennifer L Ridgeway, et al.
The Journal of Allergy and Clinical Immunology
|
May 22, 2017
X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability
Beatriz E Marciano, Christa S Zerbe, E Liana Falcone, et al.
Frontiers in Pediatrics
|
February 14, 2022
Global PARITY: Study Design for a Multi-Centered, International Point Prevalence Study to Estimate the Burden of Pediatric Acute Critical Illness in Resource-Limited Settings
Qalab Abbas, Adrian Holloway, Paula Caporal, et al.
Cell Reports. Medicine
|
July 9, 2024
Longitudinal analysis of the lung proteome reveals persistent repair months after mild to moderate COVID-19
Shreya M Kanth, Julio A Huapaya, Salina Gairhe, et al.
Page
of 86